Article Details

Moderna (MRNA) Beats on Q1 Earnings, to Start Two Late Studies - May 4, 2022 - Zacks

Retrieved on: 2022-05-04 15:54:14

Tags for this article:

Click the tags to see associated articles and topics

Moderna (MRNA) Beats on Q1 Earnings, to Start Two Late Studies - May 4, 2022 - Zacks. View article details on hiswai: https://www.zacks.com/stock/news/1915766/moderna-mrna-beats-on-q1-earnings-to-start-two-late-studies

Excerpt

Moderna's (MRNA) Spikevax sales beat expectations. The company plans to start late-stage studies for Omicron-containing bivalent booster and ...

Article found on: www.zacks.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up